A randomised, double-blind, placebo- and active-controlled, parallel-arm, multicentre study to assess efficacy, pharmacokinetics, safety and tolerability of multiple dose levels of abediterol administered once daily for four weeks, in patients with asthma symptomatic on inhaled corticosteroids
Latest Information Update: 06 Jun 2019
At a glance
- Drugs Abediterol (Primary) ; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Apr 2019 This trial has been completed in Hungary, according to European Clinical Trials Database.
- 16 Dec 2017 Status changed from not stated to recruiting.
- 07 Sep 2017 New trial record